[go: up one dir, main page]

MA30387B1 - Inhibiteurs de la renine au traitement de l'hypertension - Google Patents

Inhibiteurs de la renine au traitement de l'hypertension

Info

Publication number
MA30387B1
MA30387B1 MA31327A MA31327A MA30387B1 MA 30387 B1 MA30387 B1 MA 30387B1 MA 31327 A MA31327 A MA 31327A MA 31327 A MA31327 A MA 31327A MA 30387 B1 MA30387 B1 MA 30387B1
Authority
MA
Morocco
Prior art keywords
methods
hypertension
treatment
renin inhibitors
interruption
Prior art date
Application number
MA31327A
Other languages
English (en)
Inventor
Andrew Satlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30387(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA30387B1 publication Critical patent/MA30387B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE DES PROCÉDÉS QUI PERMETTENT DE PRÉVENIR OU TRAITER L'HYPERTENSION OU D'EN RETARDER LA PROGRESSION, LESQUELS PROCÉDÉS CONSISTENT À ADMINISTRER À UN ANIMAL À SANG CHAUD UNE QUANTITÉ THÉRAPEUTIQUEMENT EFFICACE D'UN INHIBITEUR DE LA RÉNINE OU D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CE DERNIER. L'INVENTION PORTE AUSSI SUR DES PROCÉDÉS QUI PERMETTENT DE PRÉVENIR LES COMPLICATIONS SECONDAIRES LIÉES À L'ARRÊT DU TRAITEMENT CONTRE L'HYPERTENSION.
MA31327A 2006-04-03 2008-10-23 Inhibiteurs de la renine au traitement de l'hypertension MA30387B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03

Publications (1)

Publication Number Publication Date
MA30387B1 true MA30387B1 (fr) 2009-05-04

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31327A MA30387B1 (fr) 2006-04-03 2008-10-23 Inhibiteurs de la renine au traitement de l'hypertension

Country Status (20)

Country Link
US (1) US20090062395A1 (fr)
EP (1) EP2004167A1 (fr)
JP (1) JP2009532494A (fr)
KR (1) KR20080108515A (fr)
CN (1) CN101415413A (fr)
AU (1) AU2007234917B2 (fr)
BR (1) BRPI0710095A2 (fr)
CA (1) CA2645260A1 (fr)
CL (1) CL2007000912A1 (fr)
IL (1) IL193905A0 (fr)
MA (1) MA30387B1 (fr)
MX (1) MX2008012729A (fr)
NO (1) NO20084625L (fr)
NZ (1) NZ571251A (fr)
RU (1) RU2008143055A (fr)
SG (1) SG170830A1 (fr)
TN (1) TNSN08383A1 (fr)
TW (1) TW200806283A (fr)
WO (1) WO2007118023A1 (fr)
ZA (1) ZA200807615B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (fr) * 2008-01-11 2009-07-16 Novartis Ag Utilisation de composés organiques
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
EP2768971A1 (fr) 2011-10-20 2014-08-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Méthodes de dépistage et de traitement du remodelage cardiaque
US20200352914A1 (en) * 2019-04-18 2020-11-12 Aerpio Pharmaceuticals, Inc. Methods of treating hypertension with activators of tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US20060013852A1 (en) * 2002-06-28 2006-01-19 Prescott Margaret F Use of organic compounds
US20040266743A1 (en) * 2003-05-09 2004-12-30 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
AR048431A1 (es) * 2004-03-17 2006-04-26 Novartis Ag Formulaciones galenicas de compuestos organicos
US20090197843A1 (en) * 2004-09-27 2009-08-06 Pantarhei Bioscience B.V. Treatment of Prevention of Unscheduled Bleeding in Women on Progestogen Containing Medication

Also Published As

Publication number Publication date
MX2008012729A (es) 2008-10-14
JP2009532494A (ja) 2009-09-10
WO2007118023A1 (fr) 2007-10-18
ZA200807615B (en) 2009-10-28
TNSN08383A1 (en) 2009-12-29
AU2007234917B2 (en) 2011-05-12
KR20080108515A (ko) 2008-12-15
CA2645260A1 (fr) 2007-10-18
NZ571251A (en) 2011-12-22
IL193905A0 (en) 2009-08-03
NO20084625L (no) 2008-11-03
RU2008143055A (ru) 2010-05-10
US20090062395A1 (en) 2009-03-05
AU2007234917A1 (en) 2007-10-18
BRPI0710095A2 (pt) 2011-08-02
CN101415413A (zh) 2009-04-22
EP2004167A1 (fr) 2008-12-24
SG170830A1 (en) 2011-05-30
CL2007000912A1 (es) 2008-03-14
TW200806283A (en) 2008-02-01

Similar Documents

Publication Publication Date Title
ZA202208783B (en) Kras mutant protein inhibitors
MX360148B (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos.
ECSP077397A (es) Preparación y uso de derivados de ácido bifenil-4-il-carbonilamino para el tratamiento de obesidad
MX346186B (es) Inhibidores de proteina cinasas.
MA30387B1 (fr) Inhibiteurs de la renine au traitement de l&#39;hypertension
WO2007067976A3 (fr) Procédé d&#39;utilisation d&#39;antagonistes de l&#39;il-6 en association avec des inihibiteurs de protéasome
WO2012135697A3 (fr) Nouveaux inhibiteurs de la rho-kinase et leurs procédés d&#39;utilisation
MX2009004984A (es) Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
WO2007128526A3 (fr) Méthodes de traitement des maladies néovasculaires
EA202192528A1 (ru) Комбинация ингибиторов pd-1 и ингибиторов lag-3 для повышения эффективности при лечении рака
MX2010008397A (es) Inhibidores del receptor de quimioquinas cxcr3.
WO2007101232A3 (fr) Inhibition de jak2 pour traiter l&#39;hypertension artérielle pulmonaire
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA200970512A1 (ru) Лечение по поводу множественной миеломы
WO2005117846A3 (fr) Traitement de maladies a l&#39;aide d&#39;inhibiteurs de l&#39;ice
MX2022002398A (es) Formas cristalinas de un inhibidor de cd73.
WO2008011114A3 (fr) Inhibiteurs de la méthionine aminopeptidase-2 et leurs procédés d&#39;utilisation
WO2007140317A3 (fr) Méthodes d&#39;utilisation d&#39;inhibiteurs de la phospholipase a2 cytosolique dans le traitement de la thrombose
WO2007056324A3 (fr) Combinaison de composes organiques pour le traitement des maladies cardiovasculaires
WO2007019153A3 (fr) Methodes de traitement de l&#39;hypertension
TN2011000459A1 (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
WO2008097468A3 (fr) Antagonistes sélectifs des récepteurs de type a de l&#39;endothéline
MX2007004020A (es) Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica.
MA32933B1 (fr) Combinaison d&#39;inhibiteurs de hspo90 et d&#39;herceptine
EA202192237A1 (ru) Кристаллические формы ингибитора jak2